G1 Therapeutics Inc

NASDAQ:GTHX   3:59:55 PM EDT
17.62
-0.05 (-0.28%)
Products

G1 Therapeutics Receives Fast Track Designation From U.S. FDA For Cosela

Published: 07/19/2021 13:44 GMT
G1 Therapeutics Inc (GTHX) - G1 Therapeutics Receives Fast Track Designation From U.S. Food and Drug Administration for Cosela™ (trilaciclib) in Combination With Chemotherapy for the Treatment of Locally Advanced Or Metastatic Triple Negative Breast Cancer.